Galenica

Galenica

GALE.SW
Bern, Switzerland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

GALE.SW · Stock Price

CHF 83.00-4.05 (-4.65%)
Market Cap: $5.3B

Historical price data

Market Cap: $5.3BPatents: 7Founded: 1900Employees: 4000-6000HQ: Bern, Switzerland

Overview

Galenica's mission is to seamlessly, powerfully, and personally meet patient and customer needs in the Swiss healthcare market through its integrated network of over 20 specialized business units. The company has successfully strengthened its market position in 2025, launching new services and advancing digitalization across all business areas, resulting in a robust 5.5% group revenue growth. Its strategy revolves around leveraging the synergies of its powerful network—combining wholesale logistics, specialized services, and direct retail access—to create value for partners and shape the future of healthcare in Switzerland.

Biotech

Technology Platform

An integrated healthcare services platform combining advanced pharmaceutical logistics, a nationwide retail pharmacy network, and proprietary digital health IT systems to connect manufacturers, providers, and patients.

Funding History

1
Total raised:$450M
IPO$450M

Opportunities

Galenica is poised to capitalize on Switzerland's aging population and the digitalization of healthcare, driving demand for pharmaceuticals and convenient patient services.
Its integrated network and specialized logistics infrastructure also position it to capture the growing market for complex biologics and advanced therapy medicines.

Risk Factors

Key risks include regulatory changes impacting drug pricing and pharmacy margins, competitive pressure from online pharmacies and other wholesalers, and execution risks associated with integrating its vast network of over 20 business units.
Cybersecurity threats to its sensitive health data also pose a significant operational and reputational hazard.

Competitive Landscape

Galenica faces competition in wholesale from players like Alloga (Mediserv) and Visana, and in retail from independent pharmacy cooperatives and online pharmacies. Its primary advantage is its unique, scaled, and integrated dual-model network, which creates significant synergies and high barriers to entry for pure-play competitors.